Kenvue (KVUE) Stock Surges as Q1 Earnings Crush Expectations Amid Kimberly-Clark Merger

TLDR

• Kenvue delivered Q1 adjusted EPS of $0.32, surpassing analyst expectations of $0.26–$0.31
• Quarterly revenue reached $3.91 billion, reflecting 4.5% annual growth and exceeding the $3.84 billion forecast
• The Skin Health and Beauty division spearheaded expansion with sales jumping 8.4%
• Kimberly-Clark’s $40 billion takeover remains scheduled for completion in H2 2026
• Forward-looking projections were withheld given the ongoing acquisition process

Kenvue (KVUE) unveiled first-quarter financial results Thursday that significantly exceeded Wall Street projections for both earnings and sales, pushing shares up approximately 1.78% during trading.

Kenvue Inc., KVUE

The consumer healthcare giant announced adjusted earnings per share of $0.32, comfortably surpassing the analyst consensus range of roughly $0.26 to $0.31. Quarterly revenue totaled $3.91 billion for the period ending March 29, representing a 4.5% increase from $3.74 billion recorded in the comparable quarter last year, while also beating the anticipated $3.84 billion figure.

Organic revenue climbed 0.7%, propelled by 1.0% positive pricing impact, though partially counterbalanced by a 0.3% decrease in volume.

KVUE shares had dipped 0.11% during pre-market activity before the earnings announcement, but the robust figures appeared to restore investor confidence.

Chief Executive Officer Kirk Perry highlighted that the organization achieved both net and organic sales advancement for the second straight quarter, accompanied by year-over-year enhancements in gross margin, operating margin, and earnings per share.

Adjusted gross profit margin expanded by 80 basis points to reach 60.8%, attributable to supply chain efficiencies and beneficial pricing strategies that mitigated inflationary pressures and tariff-related challenges. Adjusted operating income margin climbed to 24.0% compared to 19.8% in the prior-year period.

Skin Health and Beauty Leads the Way

The Skin Health and Beauty division emerged as the top performer, recording net sales growth of 8.4% to reach $1.06 billion. Flagship brands including Neutrogena and Aveeno fueled worldwide consumer demand.

Self Care increased 1.9% while Essential Health advanced 4.9%. The Self Care category faced headwinds from an unusually mild cold and flu season throughout key markets.

The organization indicated its ongoing restructuring initiative is projected to generate pre-tax expenses totaling approximately $250 million throughout the current year.

Kimberly-Clark Deal Shapes the Outlook

Kenvue opted not to provide forward-looking guidance because of the pending $40 billion acquisition by Kimberly-Clark, anticipated to finalize during the second half of 2026, contingent upon international regulatory clearances.

Kimberly-Clark shares advanced roughly 2.05% during the session, as the earnings report was perceived positively for the acquiring company.

The post Kenvue (KVUE) Stock Surges as Q1 Earnings Crush Expectations Amid Kimberly-Clark Merger appeared first on Blockonomi.